Institutional investors purchased a net $1.7 million shares of OPK during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 14.17% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.0 Million shares of OPKO Health Inc
DIMENSIONAL FUND ADVISORS, INC. Bought 812.9 Thousand shares of OPKO Health Inc
MORGAN STANLEY SMITH BARNEY LLC ... Bought 683.1 Thousand shares of OPKO Health Inc